OBJECTIVE: HAART has changed morbidity and mortality in the HIV-infected population dramatically. We aimed to estimate the use of healthcare facilities in HIV-infected patients after the introduction of HAART. DESIGN: This is a prospective nationwide cohort study. METHODS: We identified all Danish HIV patients and a cohort of population controls matched on sex and date of birth. The study period was 1995-2007. We calculated inpatient admission rates and outpatient visit rates stratified by medical speciality and International Classification of Diseases-10 diagnose categories. Relative risks were computed. RESULTS: Four thousand, seven hundred and sixty HIV-infected patients and 23 800 population controls were identified. Overall inpatient admission rates [95% confidence interval (CI)] for HIV-infected patients decreased from 90 (88-93) to 57 (56-58)/100 person-years in the study period. The risk ratio (95% CI) fell from 6.2 (6.0-6.5) to 3.1 (3.1-3.2) predominantly due to reduced inpatient admission rates to departments of infectious diseases. The overall outpatient visit rates (95% CI) for the HIV-infected patients increased from 744 (737-751) to 877 (872-882)/100 person-years, mainly due to visits at departments other than infectious diseases. A marked increase in outpatient visit rates (95% CI) in the background population decreased the risk ratio from 16.5 (16.2-16.8) to 7.1 (7.0-7.2). We observed a decreased relative risk of inpatient admissions and outpatient visits due to cancers and a small increase in relative risk due to cardiovascular disease. CONCLUSION: After the introduction of HAART, the inpatient treatment of HIV-infected patients has decreased, especially at departments of infectious disease. In contrast, this population's use of outpatient facilities has increased in noninfectious disease specialities.
OBJECTIVE: HAART has changed morbidity and mortality in the HIV-infected population dramatically. We aimed to estimate the use of healthcare facilities in HIV-infectedpatients after the introduction of HAART. DESIGN: This is a prospective nationwide cohort study. METHODS: We identified all Danish HIVpatients and a cohort of population controls matched on sex and date of birth. The study period was 1995-2007. We calculated inpatient admission rates and outpatient visit rates stratified by medical speciality and International Classification of Diseases-10 diagnose categories. Relative risks were computed. RESULTS: Four thousand, seven hundred and sixty HIV-infectedpatients and 23 800 population controls were identified. Overall inpatient admission rates [95% confidence interval (CI)] for HIV-infectedpatients decreased from 90 (88-93) to 57 (56-58)/100 person-years in the study period. The risk ratio (95% CI) fell from 6.2 (6.0-6.5) to 3.1 (3.1-3.2) predominantly due to reduced inpatient admission rates to departments of infectious diseases. The overall outpatient visit rates (95% CI) for the HIV-infectedpatients increased from 744 (737-751) to 877 (872-882)/100 person-years, mainly due to visits at departments other than infectious diseases. A marked increase in outpatient visit rates (95% CI) in the background population decreased the risk ratio from 16.5 (16.2-16.8) to 7.1 (7.0-7.2). We observed a decreased relative risk of inpatient admissions and outpatient visits due to cancers and a small increase in relative risk due to cardiovascular disease. CONCLUSION: After the introduction of HAART, the inpatient treatment of HIV-infectedpatients has decreased, especially at departments of infectious disease. In contrast, this population's use of outpatient facilities has increased in noninfectious disease specialities.
Authors: Thibaut Davy-Mendez; Sonia Napravnik; David A Wohl; Amy L Durr; Oksana Zakharova; Claire E Farel; Joseph J Eron Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Frederik N Engsig; Jan Gerstoft; Gitte Kronborg; Carsten S Larsen; Gitte Pedersen; Anne M Audelin; Louise B Jørgensen; Niels Obel Journal: Clin Epidemiol Date: 2010-08-09 Impact factor: 4.790
Authors: Stephen A Berry; Kelly A Gebo; Richard M Rutstein; Keri N Althoff; P Todd Korthuis; Aditya H Gaur; Stephen A Spector; Robert Warford; Baligh R Yehia; Allison L Agwu Journal: Pediatr Infect Dis J Date: 2014-05 Impact factor: 2.129
Authors: José Medrano; Alejando Álvaro-Meca; Alexandre Boyer; María A Jiménez-Sousa; Salvador Resino Journal: Crit Care Date: 2014-08-27 Impact factor: 9.097
Authors: Claire E Kendall; Jenna Wong; Monica Taljaard; Richard H Glazier; William Hogg; Jaime Younger; Douglas G Manuel Journal: BMC Health Serv Res Date: 2015-02-15 Impact factor: 2.655
Authors: Luis M Beltrán; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Jesús Egido; Juan García-Puig; Juan Antonio Moreno Journal: Vasc Health Risk Manag Date: 2015-01-06